Cargando…
Nucleic Acid Vaccines against SARS-CoV-2
The coronavirus disease 2019 (COVID-19) has spread worldwide and imposed a substantial burden on human health, the environment, and socioeconomic development, which has also accelerated the process of nucleic acid vaccine development and licensure. Nucleic acid vaccines are viral genetic sequence-ba...
Autores principales: | Liu, Ying, Ye, Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695141/ https://www.ncbi.nlm.nih.gov/pubmed/36366358 http://dx.doi.org/10.3390/vaccines10111849 |
Ejemplares similares
-
Functional nucleic acids as potent therapeutics against SARS-CoV-2 infection
por: Chen, Jingran, et al.
Publicado: (2023) -
Nucleic Acid Testing of SARS-CoV-2
por: Yoo, Hee Min, et al.
Publicado: (2021) -
Conventional and Microfluidic Methods for the Detection of Nucleic Acid of SARS-CoV-2
por: Song, Weidu, et al.
Publicado: (2022) -
Nucleic Acid-Based Diagnostic Tests for the Detection SARS-CoV-2: An Update
por: Yu, Choo Yee, et al.
Publicado: (2021) -
Nucleic Acid and Immunological Diagnostics for SARS-CoV-2: Processes, Platforms and Pitfalls
por: Premraj, Avinash, et al.
Publicado: (2020)